Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Primary Progressive Aphasia and Apraxia of Speech With High Definition Transcranial Direct Current Stimulation (HDtDCS-PPA/PAOS)

NCT05368350 is registered in ClinicalTrials.gov with The University of Texas at Dallas as lead sponsor.

NCT NCT05368350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Primary Progressive Aphasia and Apraxia of Speech With High Definition Transcranial Direct Current Stimulation (HDtDCS-PPA/PAOS)
Lead sponsor
The University of Texas at Dallas
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 1, 2022
Completion date
April 16, 2027
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apraxia of speech, primary progressive aphasia